Trial
NCT02885649
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI)
Condition
Clear Cell Renal Cell Carcinoma
Intervention
Enzalutamide
Why stopped
Funding unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-16